News & Filings
LALPATHLAB \u2014 Recent Activity
2 items in the last 14 days
AI Summary
Dr. Lal PathLabs Ltd has reported steady revenue growth in its recent quarterly earnings, which may impact its stock performance. As a retail investor, it's essential to consider this information when evaluating your investment portfolio and making informed decisions. The company's consistent revenue growth could potentially influence its financials and stock price in the future.
Dr. Lal PathLabs Ltd (BOM:539524) Q3 2026 Earnings Call Highlights: Steady Revenue Growth Amid ...
Despite challenges, Dr. Lal PathLabs Ltd (BOM:539524) reports a 10.6% revenue increase, driven by strategic focus on organic growth and preventive healthcare.
Click to open →
Dr. Lal PathLabs Ltd (BOM:539524) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Dr. Lal PathLabs Ltd (BOM:539524) reports a robust 10.5% revenue increase and significant PAT growth, while expanding its footprint with 18 new labs.
Click to open →
Get alerts for important filings
Add LALPATHLAB to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.